1. Anon. Nebivolol. Drugs of the Future 14: 957–959, 1989
2. De Crée J. Non-invasive cardiac haemodynamics of nebivolol: an overview. First International Nebivolol Investigators’ Meeting, Antwerp, 13–16 September, 1990
3. Lee EJD, Williams KM. Chirality: clinical pharmacokinetics and pharmacodynamic considerations. Clinical Pharmacokinetics 18: 339–345, 1990
4. Mannens G, Meuldermans W, Mostmans E, Verboven P, Heykants J. Plasma protein binding and blood distribution of the potent β1-adrenoceptor antagonist nebivolol in rat, dog and human. Proceedings of the International Symposium on Plasma Binding of Drugs and its Consequences, Ghent, 27–28 September, 1990
5. Van de Water A, Xhonneux R, Reneman R. A comparison of the cardiovascular profile of dl-nebivolol, its enantiomers and atenolol. First International Nebivolol Investigator’s Meeting, Antwerp, 13–16 September, 1990